Currently, there are a few validated mutant genes responsible for the activation of mTOR signaling in HNSCC, one of the pathways affected by these mutations is the PI3K-AKT-mTOR pathway, which is activated by EGFR hyperactivation via some types of genetic and epigenetic strategies. Here, PIK3CA is linked to head and neck squamous cell carcinoma.